Form 4 for IMMX Immix Biopharma, Inc.
Accepted 2024-05-20 00:00:00 ET · period of report 2024-05-20 · accession 0001493152-24-020776 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MI | 2024-05-20 | 2024-05-20 | IMMX | Morris Gabriel S | CFO, Dir | A - Grant | — | +48.3K | 270.8K | +22% | — |
| 2024-05-20 | 2024-05-20 | IMMX | Morris Gabriel S | CFO, Dir | A - Grant | — | +194.2K | 280.0K | +226% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-20 | A | A | 24,141 | — | 24,141 | I | — | — | (F1) Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity. |
| 2 | Common | Common Stock | 2024-05-20 | A | A | 194,218 | — | 280,034 | D See footnote | — | — | (F1) Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity. (F2) Gabriel Morris is the Managing Partner and Sole Member of Alwaysraise LLC ("Alwaysraise") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by Alwaysraise, except to the extent of his pecuniary interest therein. |
| 3 | Common | Common Stock | 2024-05-20 | A | A | 24,141 | — | 270,844 | I See footnote | — | — | (F1) Received in exchange for shares of common stock of Nexcella, Inc. which were held by the Reporting Person, which entity was merged with and into the Issuer on May 20, 2024, with the Issuer continuing as the surviving entity. (F3) Gabriel Morris is the Managing Partner of Alwaysraise Ventures I Investments, LLC ("Alwaysraise Ventures"), the general partner of Alwaysraise Ventures I, LP. ("AVILP") and in such capacity has the right to vote and dispose of the securities held by such entity. Mr. Morris disclaims beneficial ownership of the securities reported herein as held by AVILP, except to the extent of his pecuniary interest therein. |